ABVC Secures $70K Payment for Revolutionary Eye Treatment Vitargus
October 8, 2025 — ABVC BioPharma receives $70K licensing payment from ForSeeCon for Vitargus®, the world's first biodegradable vitreous substitute. Learn about this breakthrough in retinal surgery technology.